TAMBOCOR TABLET 100MG

C01BC04(WHO) AU:S4(Prescription only)UK:POM(Prescription only)US:℞-only (RS)-N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide 54143-55-4Y 3356 2560 DB01195Y 3239Y K94FTS1806 D07962Y CHEBI:75984N ChEMBL652Y DTXSID8023054 Interactive image FC(F)(F)COc2cc(C(=O)NCC1NCCCC1)c(OCC(F)(F)F)cc2 InChI=1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26)YKey:DJBNUMBKLMJRSA-UHFFFAOYSA-NY Flecainideis a medication used to prevent and ‍‍‍‍‍‍​​​‍​​​​​​treatabnormally fast heart rates.This includesventricularandsupraventricular tachycardias.Its use is only recommended in those with dangerous arrhythmias or when significant symptoms cannot be managed with other treatments.Its use does not decrease a person's risk of death.It is takenby mouthorinjection into a vein. Common side effects include dizziness, problems seeing, shortness of breath, chest pain, and tiredness.Serious side effects may includecardiac arrest,arrhythmias, andheart failure.It may be used inpregnancy, but has not been well studied in this population.Use is not recommended in those withstructural heart diseaseorischemic heart disease.Flecainide is a class Icantiarrhythmic agent.It works by decreasing the entry ofsodiumin heart cells, causing prolongation of thecardiac action potential. Flecainide was approved for medical use in the United States in 1985.It is available as ageneric medication.In 2023, it was the 223rd most commonly prescribed medication in the United States, with more than 1million prescriptions.